EGFR Clinical Trial Hi everyone, Is anyone doing specific EGFR clinical trials? TIA
EGFR Clinical Trials - What You Should Know
Great question! Yes, there are active EGFR-targeted clinical trials, and I can help you understand what's available and how to find them.
What EGFR Means (Quick Context)
EGFR (epidermal growth factor receptor) is a protein found on cancer cells that helps them grow. When your tumor has an EGFR mutation or overexpression, it means the cancer is "addicted" to this growth signal—which is actually good news because doctors can target it specifically with drugs.
Current EGFR Trial Landscape
According to resources from CancerPatientLab webinars on clinical trial matching, there are multiple ongoing EGFR-targeted trials, particularly for:
- EGFR exon 20 insertions (a specific type of EGFR mutation)
- Standard EGFR mutations (like exon 19 deletions and L858R mutations)
- Combination trials pairing EGFR inhibitors with other drugs
Real Example from the Field
According to Chris Beardmore's work on clinical trial access, researchers have successfully identified and enrolled patients with EGFR exon 20 insertion mutations in targeted trials. They've enrolled patients at multiple sites within just 2 months by using accelerated trial matching processes—showing that these trials ARE actively recruiting.
How to Find EGFR Trials Relevant to YOUR Case
Step 1: Get Your Genomic Testing
- You'll need NGS (next-generation sequencing) testing to identify your specific EGFR mutation type
- According to Selin Kurnaz from Massive Bio, NGS testing is crucial because "a huge portion of the clinical trial world is targeted therapy, precision medicine"
- Different EGFR mutations respond to different drugs, so knowing your specific mutation matters
Step 2: Use Trial Matching Services The webinars highlight several approaches:
- Massive Bio - Uses AI to match your specific mutation and treatment history to appropriate trials
- TrialMatch platforms - Screen trials based on your genomic profile and medical history
- NCI's trial database - National Cancer Institute maintains comprehensive trial listings
Step 3: Key Questions to Ask Your Oncologist
- "Do I have NGS testing results that show my specific EGFR mutation type?" (This determines which trials you qualify for)
- "Are there EGFR-targeted trials available for my specific mutation at nearby cancer centers?"
- "What phase are these trials in, and what's the drug being tested?" (Phase 1 vs. Phase 2/3 have different risk/benefit profiles)
- "Have I exhausted standard EGFR inhibitors, or would a trial be appropriate now?"
- "What are the travel requirements and is travel covered?" (According to the webinars, some trials cover travel, others don't—depends on the sponsor)
Important Context About Trial Access
According to Sumit Subudhi's advice on trial strategy: Don't wait until you've exhausted all standard treatments before considering trials. Strategic trial placement between standard therapies can preserve your options and potentially access newer approaches earlier.
Major cancer centers with strong EGFR trial programs include:
- MD Anderson Cancer Center
- Memorial Sloan Kettering
- UCSF
- Johns Hopkins
- Duke University
- Fred Hutchinson Cancer Center
These institutions often have multiple EGFR trials running simultaneously.
Next Steps
- Confirm your NGS results - Make sure you have documented EGFR mutation type
- Contact a trial matching service - They can screen hundreds of trials against your specific profile
- Consult at an academic cancer center - They'll have the most current trial information and can discuss strategic timing
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 3, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with clinical trials for cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about General
- Should I join a cancer clinical trial
- Are there any clinical trials I might be eligible for
- Are clinical trials free for cancer patients
- What questions should I ask about clinical trials for cancer
- What clinical trials are available for pancreatic cancer
- Finding the Best Clinical Trial webinar
- What is the difference between phase 1, 2, and 3 cancer clinical trials
- How do I use my tumor's DNA to find clinical trials